A THERAPEUTIC TRIAL FOR ANGELMAN SYNDROME

天使综合症的治疗试验

• 批准号: 7607309
• 负责人: Wen-Hann Tan
• 金额: $ 1.74万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607309
• 关键词: Angelman Syndrome; Betaine; Child; Computer Retrieval of Information on Scientific Projects Database; Creatine; Funding; Grant; Institution; Research; Research Personnel; Resources; Source; Therapeutic; Therapy Clinical Trials; United States National Institutes of Health; Vitamin B 12; design

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study has been designed to evaluate the possible therapeutic benefits of L-5-methyltetrahydrofolate (Metafolin), vitamin B12, creatine and betaine in children with Angelman Syndrome (AS).

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究旨在评估L-5-甲基四氢叶酸盐（Metafolin），维生素B12，肌酸和Betaine在Angelman综合征（AS）儿童中的可能益处。